Genomic DNA from Campylobacter hominis strain LMG 19568 [ATCC® BAA-381™]
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
dried Total DNA: At least 5 μg in 1X TE buffer OD260/OD280: 1.6 to 2.1
Preceptrol®
no
Genome Sequenced Strain
Campylobacter hominis ATCC BAA-381, complete genome
Type Strain
yes
Comments
Genome sequenced strain
This preparation of high molecular weight DNA is appropriate for use in the polymerase chain reaction (PCR)* process and other molecular biology applications.
*the PCR process is covered by patents owned by Hoffmann-La Roche Inc. Use of the PCR process requires a license.
Name of Depositor
ATCC
Special Collection
NCRR Contract, DNA
Chain of Custody
ATCC <-- BCCM/LMG Laboratory of Microbiology <-- P. Vandamme, Univ. Ghent <-- S. On, Danish Veter. Lab, Copenhagan, Denmark
References
Lawson AJ, et al. Campylobacter hominis sp. nov., from the human gastrointestinal tract. Int. J. Syst. Evol. Microbiol. 51: 651-660, 2001. PubMed: 11321111
Cross References
Nucleotide (GenBank) :
NC_009714
Campylobacter hominis ATCC BAA-381, complete genome
